Hepatitis A and B vaccine (Merck Sharp & Dohme)
甲肝/乙肝疫苗（Merck Sharp & Dohme）
Report date: 2022/11/27 16:45:01
Base Information
Drug NameHepatitis A and B vaccine (Merck Sharp & Dohme)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme Corp
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A